Helmut Jeggle
Presidente en BIONTECH SE .
Fortuna: 147 M $ al 30/11/2025
Perfil
Helmut Jeggle es un empresario que ha estado al frente de 23 empresas diferentes. En la actualidad, ocupa el cargo de Presidente del Consejo de Supervisión de BioNTech SE, Director General de AT Newtec GmbH, Codirector General de Jossa Arznei GmbH, Codirector General de Santo Service GmbH, Director General de Avitop GmbH, Codirector General de Neuraxpharm Holding GmbH, Director General y Director Financiero de Nx Biotech GmbH, Director General de Horus Sentilo Projektentwicklungsgesellschaft mbH, Director General de Salvia GmbH, Codirector General de SWB Holding GmbH (Bayern), Codirector General de A&T Grundstck 1 GmbH, Codirector de A&T Grundstck 2 GmbH, Codirector de Palais Berlin 1 GmbH, Presidente del Consejo de Supervisión de AiCuris Anti-infective Cures GmbH, Codirector de Santo Holding (Deutschland) GmbH, Director de Operaciones y Codirector de Athos Service GmbH, Codirector de Objektgesellschaft Berlin Passauer Strae 5-7 mbH, Codirector de Objektgesellschaft Mnchen Jahnstrae 41 und Klenzestrae, Director General de Santo Venture Capital GmbH, Director Ejecutivo y Socio General de ATHOS KG y Director General de ATS Beteiligungsverwaltung GmbH. También es codirector general de AT Impf GmbH y director general de Apceth Biopharma Manufacturing Co. Gmbh y en el consejo de otras 6 empresas. En el pasado, Helmut Jeggle ocupó el cargo de Director General de Klinge Pharma GmbH (Bayern), Presidente del Consejo de Administración de Sidroga AG, Director General de apceth Biopharma GmbH, Jefe de Planificación y Análisis de Negocios de H e x a l AG y Jefe de Planificación y Análisis de Negocios de Sandoz International GmbH. Helmut Jeggle se licenció en la Universidad de Ciencias Aplicadas de Neu-Ulm y obtuvo un MBA en el Instituto de Gestión y Tecnología de Stuttgart GmbH.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BIONTECH SE 0,59 % | 31/12/2024 | 1.425.967 ( 0,59 % ) | 147 M $ | 30/11/2025 |
Últimas noticias acerca de Helmut Jeggle
Cargos activos de Helmut Jeggle
| Empresas | Cargo | Inicio |
|---|---|---|
| BIONTECH SE | Presidente | 02/06/2008 |
| 4SC AG | Director/Miembro de la Junta | 05/06/2008 |
| TONIES SE | Director/Miembro de la Junta | 27/11/2021 |
ATS Beteiligungsverwaltung GmbH
ATS Beteiligungsverwaltung GmbH Investment ManagersFinance ATS Beteiligungsverwaltung is an active manager which invests in selected German companies in the biotech sector. | Inversor de Capital Privado | 17/08/2018 |
A&T Grundstück 2 GmbH
A&T Grundstück 2 GmbH Buys and sell land, buildings & apartments | Director Ejecutivo | - |
Palais Berlin 1 GmbH
Palais Berlin 1 GmbH Engages in buying and selling of land, buildings and flats | Director Ejecutivo | - |
Objektgesellschaft München Jahnstraße 41 und Klenzestraße
Objektgesellschaft München Jahnstraße 41 und Klenzestraße Real Estate DevelopmentFinance Rents and leases residential properties, buildings and apartments | Director Ejecutivo | - |
IQM Finland Oy
IQM Finland Oy Develops quantum computers | Director/Miembro de la Junta | 24/03/2021 |
LBG 2 GmbH
LBG 2 GmbH Provides residential real estate services | Director Ejecutivo | - |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
| ░░░░░░░ ░░░░ ░░░░░ ░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
Antiguos cargos conocidos de Helmut Jeggle.
| Empresas | Cargo | Fin |
|---|---|---|
| ░░░░░ ░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formación de Helmut Jeggle.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 46 |
|---|---|
4SC AG
4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
Santo Holding (Deutschland) GmbH
Santo Holding (Deutschland) GmbH Financial ConglomeratesFinance Operates as an investment holding company | Finance |
Hexal AG
Hexal AG Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products | Health Technology |
Ganymed Pharmaceuticals AG
Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Develops antibodies for the treatment of solid cancers | Health Technology |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
Vanguard AG
Vanguard AG Miscellaneous Commercial ServicesCommercial Services Specializes in process optimization of medical devices | Commercial Services |
ATS Beteiligungsverwaltung GmbH
ATS Beteiligungsverwaltung GmbH Investment ManagersFinance ATS Beteiligungsverwaltung is an active manager which invests in selected German companies in the biotech sector. | Finance |
AFFiRiS AG
AFFiRiS AG Medical/Nursing ServicesHealth Services Develops and produces vaccines | Health Services |
APK AG
APK AG Chemicals: SpecialtyProcess Industries Produces plastic granules for recycling sector | Process Industries |
Athos Service GmbH
Athos Service GmbH Financial ConglomeratesFinance Operates as an investment company which focuses on the pharmaceutical business | Finance |
BioNTech SE
BioNTech SE BiotechnologyHealth Technology Develops innovative therapeutics and biomarker-based diagnostic products | Health Technology |
AT Newtec GmbH
AT Newtec GmbH Financial ConglomeratesFinance Provides investment and management services | Finance |
AiCuris GmbH & Co. KG
AiCuris GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Provides research and development services for antiviral and antibacterial agents | Commercial Services |
Jossa Arznei GmbH
Jossa Arznei GmbH MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Sidroga AG | |
Objektgesellschaft Berlin Passauer Straße 5-7 mbH
Objektgesellschaft Berlin Passauer Straße 5-7 mbH Real Estate DevelopmentFinance Rents, leases and owns land, buildings and apartments | Finance |
Objektgesellschaft München Jahnstraße 41 und Klenzestraße
Objektgesellschaft München Jahnstraße 41 und Klenzestraße Real Estate DevelopmentFinance Rents and leases residential properties, buildings and apartments | Finance |
AT Impf GmbH
AT Impf GmbH Finance/Rental/LeasingFinance Offers purchasing services | Finance |
CorTec GmbH
CorTec GmbH Develops a neuro-technological platform for brain activity measurement and stimulation | |
Pharma Radebeul GmbH
Pharma Radebeul GmbH Rentals and leases industrial machinery | |
Santo Service GmbH
Santo Service GmbH Offers construction and management services for real estate | |
Santo Vermögensverwaltung GmbH
Santo Vermögensverwaltung GmbH Provides asset management services | |
Avitop GmbH | |
Neula Holding GmbH
Neula Holding GmbH Provides investment services | |
Neu-Ulm University of Applied Sciences
Neu-Ulm University of Applied Sciences Functions as a College/University | |
SiO2 Medical Products, Inc.
SiO2 Medical Products, Inc. Manufactures syringes, vials and blood tubes | |
Santo Venture Capital GmbH
Santo Venture Capital GmbH Santo Venture Capital invests in companies located in Germany. The firm focuses on healthcare, biopharmaceutical, energy, e-commerce and logistics sectors. It participates in early stage capital transactions. | |
Stuttgart Institute of Management & Technology GmbH
Stuttgart Institute of Management & Technology GmbH Functions as a College/University | |
Minaris Regenerative Medicine GmbH
Minaris Regenerative Medicine GmbH Develops cell-based and gene therapy products | |
Nx Biotech GmbH | |
Horus Sentilo Projektentwicklungsgesellschaft mbH
Horus Sentilo Projektentwicklungsgesellschaft mbH Provides investment management services | |
Salvia GmbH
Salvia GmbH Salvia invests in companies located in Germany. The firm focuses on companies operating in the fields of deep technology and science. It participates in early-stage capital requirements. | |
Solaris Pharma Corp.
Solaris Pharma Corp. Develops and distributes dermatology pharmaceutical product | |
Dr. Ernst Strüngmann Foundation gGmbH
Dr. Ernst Strüngmann Foundation gGmbH Engages in research and development on biotechnology | |
ATB GmbH
ATB GmbH Functions as an investment holding company | |
LBG 2 GmbH
LBG 2 GmbH Provides residential real estate services | |
Apceth Biopharma Manufacturing Co. Gmbh
Apceth Biopharma Manufacturing Co. Gmbh Engages in research and development in natural sciences, engineering, agricultural sciences and medicine | |
Klinge Pharma GmbH (Bayern)
Klinge Pharma GmbH (Bayern) Manufactures pharmaceutical products | |
Aicuris Anti-Infective Cures AG
Aicuris Anti-Infective Cures AG Engages in research and development in natural sciences, engineering, agricultural sciences and medicines | |
IQM Finland Oy
IQM Finland Oy Develops quantum computers | |
SWB Holding GmbH (Bayern)
SWB Holding GmbH (Bayern) Provides investment services | |
A&T Grundstück 1 GmbH
A&T Grundstück 1 GmbH Engages in buying and selling of commercial premises & non-residential buildings | |
A&T Grundstück 2 GmbH
A&T Grundstück 2 GmbH Buys and sell land, buildings & apartments | |
Palais Berlin 1 GmbH
Palais Berlin 1 GmbH Engages in buying and selling of land, buildings and flats | |
ATHOS KG
ATHOS KG Functions as an investment holding company | |
tonies SE
tonies SE Manufactures children's digital entertainment products |
- Bolsa de valores
- Insiders
- Helmut Jeggle
















